Targeting the latent reservoir for HIV-1

S Sengupta, RF Siliciano - Immunity, 2018 - cell.com
Antiretroviral therapy can effectively block HIV-1 replication and prevent or reverse
immunodeficiency in HIV-1-infected individuals. However, viral replication resumes within …

Intratumoral heterogeneity: more than just mutations

K Hinohara, K Polyak - Trends in cell biology, 2019 - cell.com
Most human tumors are composed of genetically and phenotypically heterogeneous cancer
cell populations, which poses a major challenge for the clinical management of cancer …

[HTML][HTML] Single-cell landscape of transcriptional heterogeneity and cell fate decisions during mouse early gastrulation

H Mohammed, I Hernando-Herraez, A Savino… - Cell reports, 2017 - cell.com
The mouse inner cell mass (ICM) segregates into the epiblast and primitive endoderm (PrE)
lineages coincident with implantation of the embryo. The epiblast subsequently undergoes …

Ex vivo analysis identifies effective HIV-1 latency–reversing drug combinations

GM Laird, CK Bullen, DIS Rosenbloom… - The Journal of …, 2015 - Am Soc Clin Investig
Reversal of HIV-1 latency by small molecules is a potential cure strategy. This approach will
likely require effective drug combinations to achieve high levels of latency reversal. Using …

Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice

A Halper-Stromberg, CL Lu, F Klein, JA Horwitz… - Cell, 2014 - cell.com
Latent reservoirs of HIV-1-infected cells are refractory to antiretroviral therapies (ART) and
remain the major barrier to curing HIV-1. Because latently infected cells are long-lived …

A DNA repair pathway can regulate transcriptional noise to promote cell fate transitions

RV Desai, X Chen, B Martin, S Chaturvedi, DW Hwang… - Science, 2021 - science.org
INTRODUCTION Fluctuations have long been known to dynamically shape microstate
distributions in physical systems. Throughout engineering,“dithering” approaches that …

An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B …

G Darcis, A Kula, S Bouchat, K Fu**aga… - PLoS …, 2015 - journals.plos.org
The persistence of latently infected cells in patients under combinatory antiretroviral therapy
(cART) is a major hurdle to HIV-1 eradication. Strategies to purge these reservoirs are …

Perspective: The promise of multi-cellular engineered living systems

RD Kamm, R Bashir, N Arora, RD Dar, MU Gillette… - APL …, 2018 - pubs.aip.org
Recent technological breakthroughs in our ability to derive and differentiate induced
pluripotent stem cells, organoid biology, organ-on-chip assays, and 3-D bioprinting have all …

A hardwired HIV latency program

BS Razooky, A Pai, K Aull, IM Rouzine, LS Weinberger - Cell, 2015 - cell.com
Biological circuits can be controlled by two general schemes: environmental sensing or
autonomous programs. For viruses such as HIV, the prevailing hypothesis is that latent …

Phenotypic noise and plasticity in cancer evolution

FJH Whiting, J Househam, AM Baker, A Sottoriva… - Trends in Cell …, 2024 - cell.com
Non-genetic alterations can produce changes in a cell's phenotype. In cancer, these
phenomena can influence a cell's fitness by conferring access to heritable, beneficial …